Comparing Aricept vs Namenda
| Aricept (donepezil) | Namenda (memantine) |
|
|---|
| Aricept (donepezil) | Namenda (memantine) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Alzheimer's Disease. Aricept may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Alzheimer's Disease. Namenda may also be used for purposes not listed in this medication guide. |
Related suggestions Popular comparisons
|
|||||||
| More about Aricept (donepezil) | More about Namenda (memantine) | ||||||||
| Ratings & Reviews | |||||||||
|
Aricept has an average rating of 5.8 out of 10 from a total of 49 ratings on Drugs.com. 43% of reviewers reported a positive effect, while 27% reported a negative effect. |
Namenda has an average rating of 5.8 out of 10 from a total of 33 ratings on Drugs.com. 48% of reviewers reported a positive effect, while 36% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Aricept side effects |
View all Namenda side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Aricept prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
|
||||||||
| Brand Names | |||||||||
| Other donepezil brands include: Adlarity, Aricept ODT | Other memantine brands include: Namenda XR | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
70 hours |
80 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 527 drugs are known to interact with Aricept:
|
A total of 43 drugs are known to interact with Namenda:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
November 25, 1996 |
October 16, 2003 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Namenda
Namenda is used to treat dementia associated with Alzheimer's disease. Learn about side effects ...
Exelon
Exelon (rivastigmine) is used to treat dementia caused by Alzheimer's or Parkinson's disease ...
Leqembi
Leqembi (lecanemab) is used to treat Alzheimer’s disease to help slow the progression of dementia s ...
Namzaric
Namzaric (memantine/donepezil) is used to treat Alzheimer's Disease. Includes Namzaric side ...
Kisunla
Kisunla (donanemab) is used to treat Alzheimer’s disease to help slow down the decline in memory, t ...
Lecanemab
Lecanemab (brand name Leqembi) is used to slow disease progression of Alzheimer’s disease in people ...
Vitamin e
Vitamin E is an antioxidant that occurs naturally in some foods and is used to treat or prevent ...
Rivastigmine
Rivastigmine is used for alzheimer's disease, lewy body dementia, parkinson's disease
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.